-
Signature
-
/s/ Stephen Feider, Attorney-in-Fact
-
Issuer symbol
-
BBNX
-
Transactions as of
-
19 Aug 2025
-
Net transactions value
-
-$185,971
-
Form type
-
4
-
Filing time
-
20 Aug 2025, 21:30:07 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Hopman Mark |
Chief Commercial Officer |
C/O BETA BIONICS, INC., 11 HUGHES, IRVINE |
/s/ Stephen Feider, Attorney-in-Fact |
20 Aug 2025 |
0002048497 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
BBNX |
Common Stock |
Options Exercise |
$82,406 |
+16,158 |
+47% |
$5.10 |
50,290 |
19 Aug 2025 |
Direct |
|
| transaction |
BBNX |
Common Stock |
Sale |
$268,376 |
-16,158 |
-32% |
$16.61 |
34,132 |
19 Aug 2025 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
BBNX |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-16,158 |
-19% |
$0.000000 |
67,084 |
19 Aug 2025 |
Common Stock |
16,158 |
$5.10 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: